Multiple gut lumen solutes and uremic toxin precursors

Multiple gut lumen solutes and uremic toxin precursors refers to a heterogeneous group of small molecules, such as indole and p-cresol, produced by the gut microbiota during the fermentation of dietary proteins (Vanholder R, et al., 2003, Kidney International). In healthy individuals, these precursors are absorbed, metabolized by the liver into uremic toxins like indoxyl sulfate and p-cresyl sulfate, and excreted by the kidneys. However, in patients with chronic kidney disease (CKD), these toxins accumulate systemically, exerting pro-inflammatory and pro-fibrotic effects that accelerate renal decline and increase cardiovascular risk (Meijers BK, et al., 2011, Nephrol Dial Transplant). These solutes serve as a therapeutic target for oral adsorbents, most notably AST-120 (Kremezin), which is a spherical carbon adsorbent designed to bind these precursors within the intestinal tract (Niwa T, 2011, Nagoya J Med Sci). By sequestering these molecules in the gut lumen, the drugs prevent their absorption and facilitate their elimination through feces, thereby reducing the circulating levels of harmful uremic toxins. This approach aims to slow the progression of CKD and manage uremic symptoms without directly interacting with cellular receptors or enzymes (Schulman G, et al., 2015, J Am Soc Nephrol).

Other names

Uremic toxin precursorsGut-derived uremic toxinsIndolep-CresolSmall water-soluble solutesProtein-bound uremic toxins (PBUTs)

Physical adsorption within the gastrointestinal lumen to prevent systemic absorption and subsequent metabolic conversion into toxic forms.